The psychostimulant methamphetamine (MA) is a highly addictive drug that has surged in
popularity over the last decade in North America. A burgeoning number of clandestine drug …

Methamphetamine (MA) is a highly addictive psychostimulant drug that principally affects
the monoamine neurotransmitter systems of the brain and results in feelings of alertness, …

Prognostic models can guide clinical management and increase statistical power in clinical
trials. The availability and adequacy of prognostic models for mild traumatic brain injury (…

At least 3 million Americans sustain a mild traumatic brain injury (mTBI) each year, and 1 in
5 have symptoms that persist beyond 1 month. Standards of mTBI care have evolved rapidly, …

Background Homelessness is a global public health concern, and traumatic brain injury (TBI)
could represent an underappreciated factor in the health trajectories of homeless and …

Objective The health of people living in marginal housing is not well characterized, particularly
from the perspective of multimorbid illness. The authors investigated this population in a …

Objective As part of an initiative led by the Brain Injury Special Interest Group Mild Traumatic
Brain Injury (TBI) Task Force of the American Congress of Rehabilitation Medicine (ACRM) …

Characterizing psychological factors that contribute to persistent symptoms after mild traumatic
brain injury (MTBI) can inform early intervention. To determine whether fear avoidance, a …

Background The “trimorbidity” of substance use disorder and mental and physical illness is
associated with living in precarious housing or homelessness. The extent to which substance …

Objectives To examine the completeness of return to work (RTW) and the degree of productivity
loss in individuals who do achieve a complete RTW after mild traumatic brain injury (…